Go offline with the Player FM app!
248. What If They're All Wrong About GLP-1 Medications?
Manage episode 465065632 series 3047232
In this thought-provoking episode, Matt challenges the current narrative surrounding GLP-1 medications (like Ozempic and Wegovy) and obesity treatment.
He poses a crucial question: Are we focusing too much on survival instead of helping people truly thrive?
Key Points:
• The difference between surviving and thriving in healthcare
• Why treating obesity as purely a genetic disease might be misguided
• Three major concerns about GLP-1 medications:
- Downstream effects (vitamin absorption, gut health, muscle loss)
- Loss of essential healthy habits
- No clear exit strategy from the medication
253 episodes
Manage episode 465065632 series 3047232
In this thought-provoking episode, Matt challenges the current narrative surrounding GLP-1 medications (like Ozempic and Wegovy) and obesity treatment.
He poses a crucial question: Are we focusing too much on survival instead of helping people truly thrive?
Key Points:
• The difference between surviving and thriving in healthcare
• Why treating obesity as purely a genetic disease might be misguided
• Three major concerns about GLP-1 medications:
- Downstream effects (vitamin absorption, gut health, muscle loss)
- Loss of essential healthy habits
- No clear exit strategy from the medication
253 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.